N-[6-amino-5-(1,3-diethylpyrazol-5-yl)-2-pyridinyl]cyclopentanecarboxamide;N-[6-amino-5-[1-ethyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]cyclopentanecarboxamide;N-[6-amino-5-[1-ethyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]cyclopent-2-ene-1-carboxamide;N-[6-amino-5-(6-methylimidazo[1,2-a]pyridin-7-yl)-2-pyridinyl]-4-methylbenzamide;N-[6-amino-5-[1-methyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]-2-bromobenzamide;N-[6-amino-5-[1-methyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]-4-(1,1-difluoroethoxy)benzamide;N-[6-amino-5-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)-2-pyridinyl]-4-methylbenzamide

C137H144BrF14N33O8 — CID 160831422

About N-[6-amino-5-(1,3-diethylpyrazol-5-yl)-2-pyridinyl]cyclopentanecarboxamide;N-[6-amino-5-[1-ethyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]cyclopentanecarboxamide;N-[6-amino-5-[1-ethyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]cyclopent-2-ene-1-carboxamide;N-[6-amino-5-(6-methylimidazo[1,2-a]pyridin-7-yl)-2-pyridinyl]-4-methylbenzamide;N-[6-amino-5-[1-methyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]-2-bromobenzamide;N-[6-amino-5-[1-methyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]-4-(1,1-difluoroethoxy)benzamide;N-[6-amino-5-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)-2-pyridinyl]-4-methylbenzamide

N-[6-amino-5-(1,3-diethylpyrazol-5-yl)-2-pyridinyl]cyclopentanecarboxamide;N-[6-amino-5-[1-ethyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]cyclopentanecarboxamide;N-[6-amino-5-[1-ethyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]cyclopent-2-ene-1-carboxamide;N-[6-amino-5-(6-methylimidazo[1,2-a]pyridin-7-yl)-2-pyridinyl]-4-methylbenzamide;N-[6-amino-5-[1-methyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]-2-bromobenzamide;N-[6-amino-5-[1-methyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]-4-(1,1-difluoroethoxy)benzamide;N-[6-amino-5-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)-2-pyridinyl]-4-methylbenzamide (PubChem CID 160831422) has the molecular formula C137H144BrF14N33O8 and a molecular weight of 2726.76 g/mol. Its IUPAC name is N-[6-amino-5-(1,3-diethylpyrazol-5-yl)-2-pyridinyl]cyclopentanecarboxamide;N-[6-amino-5-[1-ethyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]cyclopentanecarboxamide;N-[6-amino-5-[1-ethyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]cyclopent-2-ene-1-carboxamide;N-[6-amino-5-(6-methylimidazo[1,2-a]pyridin-7-yl)-2-pyridinyl]-4-methylbenzamide;N-[6-amino-5-[1-methyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]-2-bromobenzamide;N-[6-amino-5-[1-methyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]-4-(1,1-difluoroethoxy)benzamide;N-[6-amino-5-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)-2-pyridinyl]-4-methylbenzamide.

Molecular Properties

• Compound Name: N-[6-amino-5-(1,3-diethylpyrazol-5-yl)-2-pyridinyl]cyclopentanecarboxamide;N-[6-amino-5-[1-ethyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]cyclopentanecarboxamide;N-[6-amino-5-[1-ethyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]cyclopent-2-ene-1-carboxamide;N-[6-amino-5-(6-methylimidazo[1,2-a]pyridin-7-yl)-2-pyridinyl]-4-methylbenzamide;N-[6-amino-5-[1-methyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]-2-bromobenzamide;N-[6-amino-5-[1-methyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]-4-(1,1-difluoroethoxy)benzamide;N-[6-amino-5-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)-2-pyridinyl]-4-methylbenzamide
• PubChem CID: 160831422
• Molecular Formula: C137H144BrF14N33O8
• Molecular Weight: 2726.76 g/mol
• Exact Mass: 2724.08
• IUPAC Name: N-[6-amino-5-(1,3-diethylpyrazol-5-yl)-2-pyridinyl]cyclopentanecarboxamide;N-[6-amino-5-[1-ethyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]cyclopentanecarboxamide;N-[6-amino-5-[1-ethyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]cyclopent-2-ene-1-carboxamide;N-[6-amino-5-(6-methylimidazo[1,2-a]pyridin-7-yl)-2-pyridinyl]-4-methylbenzamide;N-[6-amino-5-[1-methyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]-2-bromobenzamide;N-[6-amino-5-[1-methyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]-4-(1,1-difluoroethoxy)benzamide;N-[6-amino-5-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)-2-pyridinyl]-4-methylbenzamide
• SMILES: CCc1cc(-c2ccc(NC(=O)C3CCCC3)nc2N)n(CC)n1.CCn1nc(C(F)(F)F)cc1-c1ccc(NC(=O)C2C=CCC2)nc1N.CCn1nc(C(F)(F)F)cc1-c1ccc(NC(=O)C2CCCC2)nc1N.Cc1ccc(C(=O)Nc2ccc(-c3cc4c(cc3C)C(C)(C)CCC4(C)C)c(N)n2)cc1.Cc1ccc(C(=O)Nc2ccc(-c3cc4nccn4cc3C)c(N)n2)cc1.Cn1nc(C(F)(F)F)cc1-c1ccc(NC(=O)c2ccc(OC(C)(F)F)cc2)nc1N.Cn1nc(C(F)(F)F)cc1-c1ccc(NC(=O)c2ccccc2Br)nc1N
• InChI: InChI=1S/C28H33N3O.C21H19N5O.C19H16F5N5O2.C18H25N5O.C17H13BrF3N5O.C17H20F3N5O.C17H18F3N5O/c1-17-7-9-19(10-8-17)26(32)31-24-12-11-20(25(29)30-24)21-16-23-22(15-18(21)2)27(3,4)13-14-28(23,5)6;1-13-3-5-15(6-4-13)21(27)25-18-8-7-16(20(22)24-18)17-11-19-23-9-10-26(19)12-14(17)2;1-18(20,21)31-11-5-3-10(4-6-11)17(30)27-15-8-7-12(16(25)26-15)13-9-14(19(22,23)24)28-29(13)2;1-3-13-11-15(23(4-2)22-13)14-9-10-16(20-17(14)19)21-18(24)12-7-5-6-8-12;1-26-12(8-13(25-26)17(19,20)21)10-6-7-14(23-15(10)22)24-16(27)9-4-2-3-5-11(9)18;2*1-2-25-12(9-13(24-25)17(18,19)20)11-7-8-14(22-15(11)21)23-16(26)10-5-3-4-6-10/h7-12,15-16H,13-14H2,1-6H3,(H3,29,30,31,32);3-12H,1-2H3,(H3,22,24,25,27);3-9H,1-2H3,(H3,25,26,27,30);9-12H,3-8H2,1-2H3,(H3,19,20,21,24);2-8H,1H3,(H3,22,23,24,27);7-10H,2-6H2,1H3,(H3,21,22,23,26);3,5,7-10H,2,4,6H2,1H3,(H3,21,22,23,26)
• InChIKey: SGVRKQAKTRIXGD-UHFFFAOYSA-N
• XLogP: 29.23
• TPSA: 591.70 Ų
• H-Bond Donors: 14
• H-Bond Acceptors: 34
• Rotatable Bonds: 27
• Heavy Atoms: 193
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2726.76
LogP ≤ 5	29.23
H-Bond Donors ≤ 5	14
H-Bond Acceptors ≤ 10	34

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of N-[6-amino-5-(1,3-diethylpyrazol-5-yl)-2-pyridinyl]cyclopentanecarboxamide;N-[6-amino-5-[1-ethyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]cyclopentanecarboxamide;N-[6-amino-5-[1-ethyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]cyclopent-2-ene-1-carboxamide;N-[6-amino-5-(6-methylimidazo[1,2-a]pyridin-7-yl)-2-pyridinyl]-4-methylbenzamide;N-[6-amino-5-[1-methyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]-2-bromobenzamide;N-[6-amino-5-[1-methyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]-4-(1,1-difluoroethoxy)benzamide;N-[6-amino-5-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)-2-pyridinyl]-4-methylbenzamide?

The IUPAC name of N-[6-amino-5-(1,3-diethylpyrazol-5-yl)-2-pyridinyl]cyclopentanecarboxamide;N-[6-amino-5-[1-ethyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]cyclopentanecarboxamide;N-[6-amino-5-[1-ethyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]cyclopent-2-ene-1-carboxamide;N-[6-amino-5-(6-methylimidazo[1,2-a]pyridin-7-yl)-2-pyridinyl]-4-methylbenzamide;N-[6-amino-5-[1-methyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]-2-bromobenzamide;N-[6-amino-5-[1-methyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]-4-(1,1-difluoroethoxy)benzamide;N-[6-amino-5-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)-2-pyridinyl]-4-methylbenzamide (CID 160831422) is N-[6-amino-5-(1,3-diethylpyrazol-5-yl)-2-pyridinyl]cyclopentanecarboxamide;N-[6-amino-5-[1-ethyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]cyclopentanecarboxamide;N-[6-amino-5-[1-ethyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]cyclopent-2-ene-1-carboxamide;N-[6-amino-5-(6-methylimidazo[1,2-a]pyridin-7-yl)-2-pyridinyl]-4-methylbenzamide;N-[6-amino-5-[1-methyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]-2-bromobenzamide;N-[6-amino-5-[1-methyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]-4-(1,1-difluoroethoxy)benzamide;N-[6-amino-5-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)-2-pyridinyl]-4-methylbenzamide.

What is the SMILES notation for N-[6-amino-5-(1,3-diethylpyrazol-5-yl)-2-pyridinyl]cyclopentanecarboxamide;N-[6-amino-5-[1-ethyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]cyclopentanecarboxamide;N-[6-amino-5-[1-ethyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]cyclopent-2-ene-1-carboxamide;N-[6-amino-5-(6-methylimidazo[1,2-a]pyridin-7-yl)-2-pyridinyl]-4-methylbenzamide;N-[6-amino-5-[1-methyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]-2-bromobenzamide;N-[6-amino-5-[1-methyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]-4-(1,1-difluoroethoxy)benzamide;N-[6-amino-5-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)-2-pyridinyl]-4-methylbenzamide?

The canonical SMILES for N-[6-amino-5-(1,3-diethylpyrazol-5-yl)-2-pyridinyl]cyclopentanecarboxamide;N-[6-amino-5-[1-ethyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]cyclopentanecarboxamide;N-[6-amino-5-[1-ethyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]cyclopent-2-ene-1-carboxamide;N-[6-amino-5-(6-methylimidazo[1,2-a]pyridin-7-yl)-2-pyridinyl]-4-methylbenzamide;N-[6-amino-5-[1-methyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]-2-bromobenzamide;N-[6-amino-5-[1-methyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]-4-(1,1-difluoroethoxy)benzamide;N-[6-amino-5-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)-2-pyridinyl]-4-methylbenzamide is CCc1cc(-c2ccc(NC(=O)C3CCCC3)nc2N)n(CC)n1.CCn1nc(C(F)(F)F)cc1-c1ccc(NC(=O)C2C=CCC2)nc1N.CCn1nc(C(F)(F)F)cc1-c1ccc(NC(=O)C2CCCC2)nc1N.Cc1ccc(C(=O)Nc2ccc(-c3cc4c(cc3C)C(C)(C)CCC4(C)C)c(N)n2)cc1.Cc1ccc(C(=O)Nc2ccc(-c3cc4nccn4cc3C)c(N)n2)cc1.Cn1nc(C(F)(F)F)cc1-c1ccc(NC(=O)c2ccc(OC(C)(F)F)cc2)nc1N.Cn1nc(C(F)(F)F)cc1-c1ccc(NC(=O)c2ccccc2Br)nc1N.

What is the InChIKey of N-[6-amino-5-(1,3-diethylpyrazol-5-yl)-2-pyridinyl]cyclopentanecarboxamide;N-[6-amino-5-[1-ethyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]cyclopentanecarboxamide;N-[6-amino-5-[1-ethyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]cyclopent-2-ene-1-carboxamide;N-[6-amino-5-(6-methylimidazo[1,2-a]pyridin-7-yl)-2-pyridinyl]-4-methylbenzamide;N-[6-amino-5-[1-methyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]-2-bromobenzamide;N-[6-amino-5-[1-methyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]-4-(1,1-difluoroethoxy)benzamide;N-[6-amino-5-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)-2-pyridinyl]-4-methylbenzamide?

The InChIKey is SGVRKQAKTRIXGD-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H33N3O.C21H19N5O.C19H16F5N5O2.C18H25N5O.C17H13BrF3N5O.C17H20F3N5O.C17H18F3N5O/c1-17-7-9-19(10-8-17)26(32)31-24-12-11-20(25(29)30-24)21-16-23-22(15-18(21)2)27(3,4)13-14-28(23,5)6;1-13-3-5-15(6-4-13)21(27)25-18-8-7-16(20(22)24-18)17-11-19-23-9-10-26(19)12-14(17)2;1-18(20,21)31-11-5-3-10(4-6-11)17(30)27-15-8-7-12(16(25)26-15)13-9-14(19(22,23)24)28-29(13)2;1-3-13-11-15(23(4-2)22-13)14-9-10-16(20-17(14)19)21-18(24)12-7-5-6-8-12;1-26-12(8-13(25-26)17(19,20)21)10-6-7-14(23-15(10)22)24-16(27)9-4-2-3-5-11(9)18;2*1-2-25-12(9-13(24-25)17(18,19)20)11-7-8-14(22-15(11)21)23-16(26)10-5-3-4-6-10/h7-12,15-16H,13-14H2,1-6H3,(H3,29,30,31,32);3-12H,1-2H3,(H3,22,24,25,27);3-9H,1-2H3,(H3,25,26,27,30);9-12H,3-8H2,1-2H3,(H3,19,20,21,24);2-8H,1H3,(H3,22,23,24,27);7-10H,2-6H2,1H3,(H3,21,22,23,26);3,5,7-10H,2,4,6H2,1H3,(H3,21,22,23,26).

What are the key properties of N-[6-amino-5-(1,3-diethylpyrazol-5-yl)-2-pyridinyl]cyclopentanecarboxamide;N-[6-amino-5-[1-ethyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]cyclopentanecarboxamide;N-[6-amino-5-[1-ethyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]cyclopent-2-ene-1-carboxamide;N-[6-amino-5-(6-methylimidazo[1,2-a]pyridin-7-yl)-2-pyridinyl]-4-methylbenzamide;N-[6-amino-5-[1-methyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]-2-bromobenzamide;N-[6-amino-5-[1-methyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]-4-(1,1-difluoroethoxy)benzamide;N-[6-amino-5-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)-2-pyridinyl]-4-methylbenzamide?

N-[6-amino-5-(1,3-diethylpyrazol-5-yl)-2-pyridinyl]cyclopentanecarboxamide;N-[6-amino-5-[1-ethyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]cyclopentanecarboxamide;N-[6-amino-5-[1-ethyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]cyclopent-2-ene-1-carboxamide;N-[6-amino-5-(6-methylimidazo[1,2-a]pyridin-7-yl)-2-pyridinyl]-4-methylbenzamide;N-[6-amino-5-[1-methyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]-2-bromobenzamide;N-[6-amino-5-[1-methyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]-4-(1,1-difluoroethoxy)benzamide;N-[6-amino-5-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)-2-pyridinyl]-4-methylbenzamide has a molecular weight of 2726.76 g/mol, XLogP of 29.23, 27 rotatable bonds, 14 hydrogen bond donors, and 34 hydrogen bond acceptors.

Where does this data come from?

All data for N-[6-amino-5-(1,3-diethylpyrazol-5-yl)-2-pyridinyl]cyclopentanecarboxamide;N-[6-amino-5-[1-ethyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]cyclopentanecarboxamide;N-[6-amino-5-[1-ethyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]cyclopent-2-ene-1-carboxamide;N-[6-amino-5-(6-methylimidazo[1,2-a]pyridin-7-yl)-2-pyridinyl]-4-methylbenzamide;N-[6-amino-5-[1-methyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]-2-bromobenzamide;N-[6-amino-5-[1-methyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]-4-(1,1-difluoroethoxy)benzamide;N-[6-amino-5-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)-2-pyridinyl]-4-methylbenzamide is sourced from PubChem (CID 160831422), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).